BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 2011;22:2257-2266. [PMID: 21343377 DOI: 10.1093/annonc/mdq758] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Yan JW, Lin JS, He XX. The emerging role of miR-375 in cancer. Int J Cancer. 2014;135:1011-1018. [PMID: 24166096 DOI: 10.1002/ijc.28563] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 15.7] [Reference Citation Analysis]
2 Jia L, Xi Q, Wang H, Zhang Z, Liu H, Cheng Y, Guo X, Zhang J, Zhang Q, Zhang L, Xue Z, Li Y, Da Y, Zhao P, Zhang R. miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity. Biochemical and Biophysical Research Communications 2017;488:425-31. [DOI: 10.1016/j.bbrc.2017.05.074] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 15.8] [Reference Citation Analysis]
3 Kee HJ, Park S, Kwon JS, Choe N, Ahn Y, Kook H, Jeong MH. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression. FEBS Lett 2013;587:2385-92. [PMID: 23770100 DOI: 10.1016/j.febslet.2013.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
4 Komatsu S, Ichikawa D, Takeshita H, Konishi H, Nagata H, Hirajima S, Kawaguchi T, Arita T, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther. 2012;12 Suppl 1:S53-S59. [PMID: 22519435 DOI: 10.1517/14712598.2012.681373] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
5 Sakharov D, Maltseva D, Knyazev E, Nikulin S, Poloznikov A, Shilin S, Baranova A, Tsypina I, Tonevitsky A. Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology. BMC Syst Biol 2019;13:19. [PMID: 30836980 DOI: 10.1186/s12918-019-0686-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
6 Liu B, Ding JF, Luo J, Lu L, Yang F, Tan XD. Seven protective miRNA signatures for prognosis of cervical cancer. Oncotarget 2016;7:56690-8. [PMID: 27447860 DOI: 10.18632/oncotarget.10678] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
7 Zehentmayr F, Hauser-Kronberger C, Zellinger B, Hlubek F, Schuster C, Bodenhofer U, Fastner G, Deutschmann H, Steininger P, Reitsamer R, Fischer T, Sedlmayer F. Hsa-miR-375 is a predictor of local control in early stage breast cancer. Clin Epigenetics 2016;8:28. [PMID: 26962366 DOI: 10.1186/s13148-016-0198-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
9 Tsang FH, Au SL, Wei L, Fan DN, Lee JM, Wong CC, Ng IO, Wong CM. MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. Front Med. 2015;9:331-343. [PMID: 26293610 DOI: 10.1007/s11684-015-0409-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
10 Yan J, Yang B, Lin S, Xing R, Lu Y. Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer. Gastric Cancer 2019;22:302-13. [DOI: 10.1007/s10120-018-0872-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
11 Tu M, Tang J, He H, Cheng P, Chen C. MiR-142-5p promotes bone repair by maintaining osteoblast activity. J Bone Miner Metab 2017;35:255-64. [PMID: 27085967 DOI: 10.1007/s00774-016-0757-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
12 Li Z, Abdalla BA, Zheng M, He X, Cai B, Han P, Ouyang H, Chen B, Nie Q, Zhang X. Systematic transcriptome-wide analysis of mRNA-miRNA interactions reveals the involvement of miR-142-5p and its target (FOXO3) in skeletal muscle growth in chickens. Mol Genet Genomics 2018;293:69-80. [PMID: 28866851 DOI: 10.1007/s00438-017-1364-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
13 Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, Lin A, Shu Q, Zhou T. Non-coding RNAs in gastric cancer. Cancer Lett 2020;493:55-70. [PMID: 32712234 DOI: 10.1016/j.canlet.2020.06.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chiurillo MA. Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review. World J Exp Med 2015; 5(2): 84-102 [PMID: 25992323 DOI: 10.5493/wjem.v5.i2.84] [Cited by in CrossRef: 158] [Cited by in F6Publishing: 145] [Article Influence: 22.6] [Reference Citation Analysis]
15 Yan JW, Liao JZ, Lin JS, He XX. Roles of miR-375 in digestive tumors. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 654-660 [DOI: 10.11569/wcjd.v22.i5.654] [Reference Citation Analysis]
16 Kwanhian W, Lenze D, Alles J, Motsch N, Barth S, Döll C, Imig J, Hummel M, Tinguely M, Trivedi P, Lulitanond V, Meister G, Renner C, Grässer FA. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med 2012;1:141-55. [PMID: 23342264 DOI: 10.1002/cam4.29] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
17 Darnet S, Moreira FC, Hamoy IG, Burbano R, Khayat A, Cruz A, Magalhães L, Silva A, Santos S, Demachki S, Assumpção M, Assumpção P, Ribeiro-dos-santos Â. High-Throughput Sequencing of miRNAs Reveals a Tissue Signature in Gastric Cancer and Suggests Novel Potential Biomarkers. Bioinform Biol Insights 2015;9s1:BBI.S23773. [DOI: 10.4137/bbi.s23773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
18 Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol 2014; 20(34): 12007-12017 [PMID: 25232237 DOI: 10.3748/wjg.v20.i34.12007] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
19 Li MH, Fu SB, Xiao HS. Genome-wide analysis of microRNA and mRNA expression signatures in cancer. Acta Pharmacol Sin 2015;36:1200-11. [PMID: 26299954 DOI: 10.1038/aps.2015.67] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
20 Ayoubian H, Ludwig N, Fehlmann T, Menegatti J, Gröger L, Anastasiadou E, Trivedi P, Keller A, Meese E, Grässer FA. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex. J Virol 2019;93:e01297-18. [PMID: 30429351 DOI: 10.1128/JVI.01297-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Liu H, Liu L, Zhu H. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data. Journal of Computational Biology 2019;26:387-95. [DOI: 10.1089/cmb.2018.0241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Shomali N, Shirafkan N, Duijf PHG, Ghasabi M, Babaloo Z, Yousefi M, Mansoori B, Asadi M, Shanehbandi D, Baghbani E, Mohammadi A, Baradaran B. Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer. J Cell Biochem 2019;120:9495-505. [PMID: 30537266 DOI: 10.1002/jcb.28225] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Tumour Biol 2016;37:6637-45. [PMID: 26643896 DOI: 10.1007/s13277-015-4550-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
24 Montasser ME, Ziv-Gal A, Brown JP, Flaws JA, Merchenthaler I. A potentially functional variant in the serotonin transporter gene is associated with premenopausal and perimenopausal hot flashes. Menopause 2015;22:108-13. [PMID: 25026114 DOI: 10.1097/GME.0000000000000291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Ding B, Gao X, Li H, Liu L, Hao X. A novel microRNA signature predicts survival in stomach adenocarcinoma. Oncotarget 2017;8:28144-53. [PMID: 28423653 DOI: 10.18632/oncotarget.15961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, Loffredo CA, Zheng YL. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One. 2012;7:e39011. [PMID: 22723919 DOI: 10.1371/journal.pone.0039011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
27 Yan W, Qian L, Chen J, Chen W, Shen B. Comparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric Cancer. J Cancer 2016;7:95-106. [PMID: 26722365 DOI: 10.7150/jca.13340] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
28 Wu X, Tan X, Fu SW. May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers? J Cancer 2015;6:1206-13. [PMID: 26535061 DOI: 10.7150/jca.12535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
29 Sun Z, Xu H. Peritoneal Carcinomatosis from Gastric Cancer: Current Considerations for Systematic Management and Future Tendencies for Identification of Valid Predictors. Ann Surg Oncol 2011;18:202-5. [DOI: 10.1245/s10434-011-1853-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Chang C, Shi H, Wang C, Wang J, Geng N, Jiang X, Wang X. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neurosci Lett. 2012;531:204-208. [PMID: 23103713 DOI: 10.1016/j.neulet.2012.10.021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
31 Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, Tang H. MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life. 2012;64:628-635. [PMID: 22539488 DOI: 10.1002/iub.1030] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
32 Wang H, Sun G, Xu P, Lv J, Zhang X, Zhang L, Wang S, Cao J, Xia Y, Xuan Z, Li B, Huang X, Jiang T, Fang L, Xu Z. Circular RNA TMEM87A promotes cell proliferation and metastasis of gastric cancer by elevating ULK1 via sponging miR-142-5p. J Gastroenterol 2021;56:125-38. [PMID: 33155080 DOI: 10.1007/s00535-020-01744-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Chen S, Lao J, Geng Q, Zhang J, Wu A, Xu D. A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer. Front Oncol 2020;10:565. [PMID: 32656071 DOI: 10.3389/fonc.2020.00565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Islam F, Gopalan V, Vider J, Lu CT, Lam AK. MiR-142-5p act as an oncogenic microRNA in colorectal cancer: Clinicopathological and functional insights. Exp Mol Pathol 2018;104:98-107. [PMID: 29337244 DOI: 10.1016/j.yexmp.2018.01.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
35 Wu C, Li M, Hu C, Duan H. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep. 2014;41:1257-1266. [PMID: 24390317 DOI: 10.1007/s11033-013-2970-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
36 Cheng D, Li J, Zhang L, Hu L. miR-142-5p suppresses proliferation and promotes apoptosis of human osteosarcoma cell line, HOS, by targeting PLA2G16 through the ERK1/2 signaling pathway. Oncol Lett 2019;17:1363-71. [PMID: 30655907 DOI: 10.3892/ol.2018.9712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
37 Zare A, Ganji M, Omrani MD, Alipoor B, Ghaedi H. Gastric Cancer MicroRNAs Meta-signature. Int J Mol Cell Med 2019;8:94-102. [PMID: 32215261 DOI: 10.22088/IJMCM.BUMS.8.2.94] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Cheng J, Liu Y, Huang W, Hong W, Wang L, Zhan X, Han Z, Ni D, Huang K, Zhang J. Computational Image Analysis Identifies Histopathological Image Features Associated With Somatic Mutations and Patient Survival in Gastric Adenocarcinoma. Front Oncol 2021;11:623382. [PMID: 33869007 DOI: 10.3389/fonc.2021.623382] [Reference Citation Analysis]
39 Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li Y, Li Z, Ng SS, Sung JJ, Shen L, Yu J. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene. 2015;34:4142-4152. [PMID: 25362853 DOI: 10.1038/onc.2014.348] [Cited by in Crossref: 91] [Cited by in F6Publishing: 102] [Article Influence: 11.4] [Reference Citation Analysis]
40 Campayo M, Navarro A, Benítez JC, Santasusagna S, Ferrer C, Monzó M, Cirera L. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS One 2018;13:e0206542. [PMID: 30388154 DOI: 10.1371/journal.pone.0206542] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
41 Wei G, Yuan Y, He X, Jin L, Jin D. Enhanced plasma miR-142-5p promotes the progression of intrahepatic cholangiocarcinoma via targeting PTEN. Exp Ther Med 2019;17:4190-6. [PMID: 31007750 DOI: 10.3892/etm.2019.7438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Singh P, Soon PS, Feige J, Chabre O, Zhao JT, Cherradi N, Lalli E, Sidhu SB. Dysregulation of microRNAs in adrenocortical tumors. Molecular and Cellular Endocrinology 2012;351:118-28. [DOI: 10.1016/j.mce.2011.09.041] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
43 Quan Y, Zhang Y, Lin W, Shen Z, Wu S, Zhu C, Wang X. Knockdown of long non-coding RNA MAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically regulating miR-375. Biochem Biophys Res Commun. 2018;497:527-534. [PMID: 29428732 DOI: 10.1016/j.bbrc.2018.02.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
44 Liu R, Zheng S, Yu K, Yu Y, Yu C, Shi W, Ge Q, Ye Z, Shao Y. Prognostic value of miR-142 in solid tumors: a meta-analysis. Biosci Rep 2021;41:BSR20204043. [PMID: 33600577 DOI: 10.1042/BSR20204043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Goeman F, Strano S, Blandino G. MicroRNAs as Key Effectors in the p53 Network. Int Rev Cell Mol Biol 2017;333:51-90. [PMID: 28729028 DOI: 10.1016/bs.ircmb.2017.04.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
46 Liang P, Lv C, Jiang B, Long X, Zhang P, Zhang M, Xie T, Huang X. MicroRNA profiling in denatured dermis of deep burn patients. Burns 2012;38:534-40. [PMID: 22360957 DOI: 10.1016/j.burns.2011.10.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
47 Liu J, Song S, Lin S, Zhang M, Du Y, Zhang D, Xu W, Wang H. Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ. Cell Prolif 2019;52:e12648. [PMID: 31199037 DOI: 10.1111/cpr.12648] [Cited by in Crossref: 18] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
48 Dahmke IN, Backes C, Rudzitis-Auth J, Laschke MW, Leidinger P, Menger MD, Meese E, Mahlknecht U. Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered. PLoS One 2013;8:e81122. [PMID: 24349037 DOI: 10.1371/journal.pone.0081122] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
49 Yuan Y, Liu X, Hao S, He Q, Shen Z. Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation. Ann Transl Med 2020;8:756. [PMID: 32647681 DOI: 10.21037/atm-20-4227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
50 Yuan H, Li M, Feng X, Zhu E, Wang B. miR-142a-5p promoted osteoblast differentiation via targeting nuclear factor IA. J Cell Physiol 2021;236:1810-21. [PMID: 32700780 DOI: 10.1002/jcp.29963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Beeharry MK, Liu WT, Yan M, Zhu ZG. New blood markers detection technology: A leap in the diagnosis of gastric cancer. World J Gastroenterol 2016; 22(3): 1202-1212 [PMID: 26811658 DOI: 10.3748/wjg.v22.i3.1202] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
52 Ding X, Wan X, Jiang H, Song H, Fang Y, Chen S, Li P, Guo J. The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses. Tumor Biol 2015;36:4017-25. [DOI: 10.1007/s13277-015-3411-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
53 Gao M, Yin H, Fei ZW. Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 2013; 19(13): 2019-2027 [PMID: 23599620 DOI: 10.3748/wjg.v19.i13.2019] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
54 Wu YS, Chen YL, Yin SG, Zhou FX. Identification of differentially expressed miRNAs and mRNAs in esophageal squamous cell cancer by gene microarray. Shijie Huaren Xiaohua Zazhi 2011; 19(36): 3687-3691 [DOI: 10.11569/wcjd.v19.i36.3687] [Reference Citation Analysis]
55 Li Y, Liu H, Shao J, Xing G. miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14. Mol Med Rep 2017;16:2652-8. [PMID: 28713899 DOI: 10.3892/mmr.2017.6937] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
56 Ragusa M, Statello L, Maugeri M, Barbagallo C, Passanisi R, Alhamdani MS, Li Destri G, Cappellani A, Barbagallo D, Scalia M, Valadi H, Hoheisel JD, Di Pietro C, Purrello M. Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications. Oncoscience 2014;1:132-57. [PMID: 25594007 DOI: 10.18632/oncoscience.19] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
57 Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27:1019-1026. [PMID: 22267008 DOI: 10.3892/or.2012.1645] [Cited by in Crossref: 182] [Cited by in F6Publishing: 180] [Article Influence: 18.2] [Reference Citation Analysis]
58 Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li Y, Li Z, Ng SS, Sung JJ. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene. 2015;34:4142-4152. [PMID: 25362853 DOI: 10.1038/onc/2014.348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M, Tan P. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation: MicroRNA dysregulation in gastric cancer. Int J Cancer 2016;138:1337-49. [DOI: 10.1002/ijc.29627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
60 Soares CT, Trombone APF, Fachin LRV, Rosa PS, Ghidella CC, Ramalho RF, Pinilla MG, Carvalho AF, Carrara DN, Soares FA, Belone AFF. Differential Expression of MicroRNAs in Leprosy Skin Lesions. Front Immunol 2017;8:1035. [PMID: 28970833 DOI: 10.3389/fimmu.2017.01035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
61 Danger R, Paul C, Giral M, Lavault A, Foucher Y, Degauque N, Pallier A, Durand M, Castagnet S, Duong Van Huyen JP, Delahousse M, Renaudin K, Soulillou JP, Brouard S. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One 2013;8:e60702. [PMID: 23577151 DOI: 10.1371/journal.pone.0060702] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
62 Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, Cstoth I, Dernies T, Toussaint L, Leclercq N, Sculier JP; European Lung Cancer Working Party. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer 2013;82:340-5. [PMID: 24007627 DOI: 10.1016/j.lungcan.2013.07.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
63 Park SK, Park YS, Ahn JY, Do EJ, Kim D, Kim JE, Jung K, Byeon JS, Ye BD, Yang DH. MiR 21-5p as a predictor of recurrence in young gastric cancer patients. J Gastroenterol Hepatol. 2016;31:1429-1435. [PMID: 26824898 DOI: 10.1111/jgh.13300] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
64 Baghery Saghchy Khorasani A, Pourbagheri-Sigaroodi A, Pirsalehi A, Safaroghli-Azar A, Zali MR, Bashash D. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. Eur J Pharmacol 2021;898:173983. [PMID: 33647255 DOI: 10.1016/j.ejphar.2021.173983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Liu S, Xiao Z, Ai F, Liu F, Chen X, Cao K, Ren W, Zhang X, Shu P, Zhang D. miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis. Biomed Pharmacother 2017;92:1119-27. [PMID: 28622713 DOI: 10.1016/j.biopha.2017.05.134] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
66 Chatterjee P, Roy D, Bhattacharyya M, Bandyopadhyay S. Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease. BMC Genomics 2017;18:721. [PMID: 28899360 DOI: 10.1186/s12864-017-4098-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
67 Chung KY, Quek JM, Neo SH, Too HP. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance. The Journal of Molecular Diagnostics 2020;22:610-8. [DOI: 10.1016/j.jmoldx.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
68 Xie SS, Jin J, Xu X, Zhuo W, Zhou TH. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications. World J Gastroenterol 2016; 22(3): 1213-1223 [PMID: 26811659 DOI: 10.3748/wjg.v22.i3.1213] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
69 Wu C, Zheng X, Li X, Fesler A, Hu W, Chen L, Xu B, Wang Q, Tong A, Burke S. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation. Oncotarget. 2016;7:14522-14536. [PMID: 26894855 DOI: 10.18632/oncotarget.7392] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
70 Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35-47.e2. [PMID: 22580099 DOI: 10.1053/j.gastro.2012.05.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
71 Liu Y, Xing R, Zhang X, Dong W, Zhang J, Yan Z, Li W, Cui J, Lu Y. miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells. DNA Repair (Amst). 2013;12:741-750. [PMID: 23835407 DOI: 10.1016/j.dnarep.2013.06.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
72 Li H, Shang H, Shu D, Zhang H, Ji J, Sun B, Li H, Xie Q. gga-miR-375 plays a key role in tumorigenesis post subgroup J avian leukosis virus infection. PLoS One 2014;9:e90878. [PMID: 24694742 DOI: 10.1371/journal.pone.0090878] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
73 Samatov TR, Galatenko VV, Senyavina NV, Galatenko AV, Shkurnikov MY, Tonevitskaya SA, Sakharov DA, Marx U, Ehrlich H, Schumacher U, Tonevitsky AG. miRNA-mediated expression switch of cell adhesion genes driven by microcirculation in chip. BioChip J 2017;11:262-9. [DOI: 10.1007/s13206-017-1305-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
74 Gao H, Wang X. Serum miRNA-142 and BMP-2 are markers of recovery following hip replacement surgery for femoral neck fracture. Exp Ther Med 2020;20:105. [PMID: 32989384 DOI: 10.3892/etm.2020.9235] [Reference Citation Analysis]
75 Zhang Y, Guan DH, Bi RX, Xie J, Yang CH, Jiang YH. Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget. 2017;8:55489-55510. [PMID: 28903436 DOI: 10.18632/oncotarget.18590] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
76 Luo Z, Cui R, Tili E, Croce C. Friend or Foe: MicroRNAs in the p53 network. Cancer Lett 2018;419:96-102. [PMID: 29330109 DOI: 10.1016/j.canlet.2018.01.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
77 Ruggieri V, Russi S, Zoppoli P, La Rocca F, Angrisano T, Falco G, Calice G, Laurino S. The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. J Clin Med 2019;8:E639. [PMID: 31075910 DOI: 10.3390/jcm8050639] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
78 Li S, Gao J, Gu J, Yuan J, Hua D, Shen L. MicroRNA-215 inhibits relapse of colorectal cancer patients following radical surgery. Med Oncol. 2013;30:549. [PMID: 23532818 DOI: 10.1007/s12032-013-0549-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
79 Yang Q, Zhang RW, Sui PC, He HT, Ding L. Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol 2015; 21(39): 10956-10981 [PMID: 26494954 DOI: 10.3748/wjg.v21.i39.10956] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
80 Liu X, Cai H, Sheng W, Huang H, Long Z, Wang Y. microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer. BMC Cancer 2018;18:1048. [PMID: 30373600 DOI: 10.1186/s12885-018-4967-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
81 Harris T, Jimenez L, Kawachi N, Fan JB, Chen J, Belbin T, Ramnauth A, Loudig O, Keller CE, Smith R, Prystowsky MB, Schlecht NF, Segall JE, Childs G. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 2012;180:917-28. [PMID: 22234174 DOI: 10.1016/j.ajpath.2011.12.004] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
82 Hudler P. Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol 2015; 21(37): 10510-10527 [PMID: 26457012 DOI: 10.3748/wjg.v21.i37.10510] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
83 Yan Z, Xu W, Xiong Y, Cheng Y, Xu H, Wang Z, Zheng G. Highly accurate two-gene signature for gastric cancer. Med Oncol 2013;30. [DOI: 10.1007/s12032-013-0584-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
84 Zhang Y, Wang M, Zang X, Mao Z, Chen Y, Mao F, Qian H, Xu W, Zhang X. CircHN1 affects cell proliferation and migration in gastric cancer. J Clin Lab Anal 2020;34:e23433. [PMID: 32608539 DOI: 10.1002/jcla.23433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
85 Pinheiro DDR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BDN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585 [PMID: 25206265 DOI: 10.3748/wjg.v20.i33.11574] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
86 Lin X, Zhao Y, Song WM, Zhang B. Molecular classification and prediction in gastric cancer. Comput Struct Biotechnol J 2015;13:448-58. [PMID: 26380657 DOI: 10.1016/j.csbj.2015.08.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
87 Yuan HL, Wang T, Zhang KH. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer. Onco Targets Ther 2018;11:3891-900. [PMID: 30013369 DOI: 10.2147/OTT.S156921] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
88 Wang L, Zhou Y, Jiang L, Lu L, Dai T, Li A, Chen Y, Zhang L. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway. Mol Cancer 2021;20:43. [PMID: 33648498 DOI: 10.1186/s12943-021-01332-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
89 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
90 Wu L, Chen J, Ding C, Wei S, Zhu Y, Yang W, Zhang X, Wei X, Han D. MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2. PLoS One 2015;10:e0130124. [PMID: 26102366 DOI: 10.1371/journal.pone.0130124] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
91 Liu L, Xiao C, Sun Q. MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway. Cutan Ocul Toxicol 2021;:1-10. [PMID: 34711123 DOI: 10.1080/15569527.2021.1994587] [Reference Citation Analysis]
92 Tsai MM, Wang CS, Tsai CY, Huang HW, Chi HC, Lin YH, Lu PH, Lin KH. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci. 2016;17:pii: E945. [PMID: 27322246 DOI: 10.3390/ijms17060945] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
93 Kraggerud SM, Hoei-Hansen CE, Alagaratnam S, Skotheim RI, Abeler VM, Rajpert-De Meyts E, Lothe RA. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev 2013;34:339-76. [PMID: 23575763 DOI: 10.1210/er.2012-1045] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
94 Sun P, Wu Y, Li X, Jia Y. miR-142-5p protects against osteoarthritis through competing with lncRNA XIST. J Gene Med 2020;22:e3158. [PMID: 31903636 DOI: 10.1002/jgm.3158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
95 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
96 Verma HK, Ratre YK, Mazzone P, Laurino S, Bhaskar LVKS. Micro RNA facilitated chemoresistance in gastric cancer: a novel biomarkers and potential therapeutics. Alexandria Journal of Medicine 2020;56:81-92. [DOI: 10.1080/20905068.2020.1779992] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
97 Chen WB, Huang JR, Yu XQ, Lin XC, Dai Y. Identification of microRNAs and their target genes in Alport syndrome using deep sequencing of iPSCs samples. J Zhejiang Univ Sci B 2015;16:235-50. [PMID: 25743125 DOI: 10.1631/jzus.B1400272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
98 Wang X, Han L, Zhou L, Wang L, Zhang LM. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network. Oncol Rep 2018;40:2659-73. [PMID: 30226545 DOI: 10.3892/or.2018.6707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
99 Liang H, Hu C, Lin X, He Z, Lin Z, Dai J. MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4. Cancer Manag Res 2020;12:13325-37. [PMID: 33380838 DOI: 10.2147/CMAR.S278691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Adnan N, Lei C, Ruan J. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis. BMC Bioinformatics 2020;21:359. [PMID: 32998692 DOI: 10.1186/s12859-020-03692-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Zhang Y, Chang L, Wu Q, Zuo F. Long non-coding RNA NEAT1 increases the aggressiveness of gastric cancer by regulating the microRNA-142-5p/JAG1 axis. Exp Ther Med 2021;22:862. [PMID: 34178135 DOI: 10.3892/etm.2021.10294] [Reference Citation Analysis]
102 Wu J, Liu X, Cai H, Wang Y. Prediction of tumor recurrence after curative resection in gastric carcinoma based on bcl-2 expression. World J Surg Oncol. 2014;12:40. [PMID: 24555747 DOI: 10.1186/1477-7819-12-40] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
103 Chiacchiarini M, Trocchianesi S, Besharat ZM, Po A, Ferretti E. Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer. Pharmacol Ther 2021;219:107708. [PMID: 33091426 DOI: 10.1016/j.pharmthera.2020.107708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Perri M, Caroleo MC, Liu N, Gallelli L, De Sarro G, Kagechika H, Cione E. 9- cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models. Experimental Cell Research 2017;354:25-30. [DOI: 10.1016/j.yexcr.2017.03.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
105 Lee SW, Park KC, Kim JG, Moon SJ, Kang SB, Lee DS, Sul HJ, Ji JS, Jeong HY. Dysregulation of MicroRNA-196b-5p and MicroRNA-375 in Gastric Cancer. J Gastric Cancer 2016;16:221-9. [PMID: 28053808 DOI: 10.5230/jgc.2016.16.4.221] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
106 Shao Y, Geng Y, Gu W, Huang J, Ning Z, Pei H. Prognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis. Dis Markers 2014;2014:626185. [PMID: 25404787 DOI: 10.1155/2014/626185] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
107 Yang S, Sheng N, Pan L, Cao J, Liu J, Ma R. microRNA-3129 promotes cell proliferation in gastric cancer cell line SGC7901 via positive regulation of pRb. Braz J Med Biol Res 2018;51:e6452. [PMID: 29791595 DOI: 10.1590/1414-431x20186452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Lou K, Chen N, Li Z, Zhang B, Wang X, Chen Y, Xu H, Wang D, Wang H. MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells. Oncol Res 2017;25:65-73. [PMID: 28081734 DOI: 10.3727/096504016X14719078133366] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]